Li-Long Pan

Title: Innovator Spotlight: Li-Long Pan and His Groundbreaking Patent in Genetic Engineering

Introduction: Li-Long Pan is an accomplished inventor based in Wuxi, China, recognized for his significant contributions to the field of genetic engineering. With a focus on developing innovative solutions for health-related challenges, he holds a patent that advances the understanding and application of lactic acid bacteria in medical use.

Latest Patents: Li-Long Pan's notable patent is titled "Cathelicidin-expressing lactic acid bacteria." This invention involves the construction of lactic acid bacteria that express the CRAMP protein through optimized nucleotide sequences. The invention demonstrates potential in preparing vaccines aimed at regulating intestinal flora disorders. Its advantages include enhancing the immune response in the intestines and promoting overall intestinal health. This recombinant product can be administered orally, stimulating a robust cellular immune response in mice, thereby displaying promising industrial prospects in vaccine development.

Career Highlights: Currently affiliated with Jiangnan University, Li-Long Pan has dedicated his career to innovative research and the practical application of genetic engineering techniques. His work is characterized by a commitment to using science to address real-world health issues.

Collaborations: Throughout his career, Li-Long Pan has collaborated with notable colleagues including Jia Sun and Diana Julien. Their collective efforts underscore a dedication to advancing the field through teamwork and shared knowledge.

Conclusion: Li-Long Pan stands out as a visionary inventor whose work has the potential to transform approaches to health, particularly concerning intestinal flora and immunity. His patent not only exhibits creativity but also suggests significant industrial applicability that could enhance health management strategies worldwide.